Currently, there are 82.75M common shares owned by the public and among those 81.64M shares have been available to trade.
Insiders at the company have transacted a total of 6 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 6 of these insider trades were purchases, accounting for 38,770 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 4.35% and -3.65% over the past three months. FBRT shares are trading -4.15% year to date (YTD), with the 12-month market performance down to -11.54% lower. It has a 12-month low price of $11.08 and touched a high of $14.79 over the same period. FBRT has an average intraday trading volume of 339.11K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.46%, -3.37%, and -3.96% respectively.
Institutional ownership of Franklin BSP Realty Trust Inc. (NYSE: FBRT) shares accounts for 61.20% of the company’s 82.75M shares outstanding.
It has a market capitalization of $1.07B and a beta (3y monthly) value of 1.38. The stock’s trailing 12-month PE ratio is 9.04, while the earnings-per-share (ttm) stands at $1.43. The company has a debt-to-equity ratio at 2.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.75% over the week and 2.66% over the month.
Analysts forecast that Franklin BSP Realty Trust Inc. (FBRT) will achieve an EPS of $Federal Realty Investment Trust for the current quarter, $100.42 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Liberty Energy Inc. while analysts give the company a high EPS estimate of $Franklin BSP Realty Trust, Inc. Comparatively, EPS for the current quarter was $Forte Biosciences, Inc. a year ago. Earnings per share for the fiscal year are expected to decrease by -16.48%, and 5.59% over the next financial year.
Looking at the support for the FBRT, a number of firms have released research notes about the stock. JMP Securities stated their Mkt Outperform rating for the stock in a research note on January 10, 2024, with the firm’s price target at $15.
